AIV Logo AIV Assistant

Loading...

 Logo Outset Medical, Inc. - OM 18.08 USD

EPS
-3.14
P/B
0.39
ROE
-126.48
Beta
1.91
Target Price
3.63 USD

18.075 USD

18.075 USD

Daily: +0.00%
Key Metrics

EPS: -3.14

Book Value: 1.32

Price to Book: 0.39

Debt/Equity: 294.91

% Insiders: 2.147%

Growth

Revenue Growth: -0.24%

Estimates

Forward P/E: -0.39

Forward EPS: -1.30

Target Mean Price: 3.63

 Logo About Outset Medical, Inc. - (OM)

Country: United States

Sector: Health Care

Website: http://www.outsetmedical.com

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Exchange Ticker
NMS (United States) OM

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
March 20, 2025 0.07
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion